Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Centers without Walls for mechanisms of neurodegeneration…

U.S. National Institutes of Health·United States of America

Centers without Walls for mechanisms of neurodegeneration in Alzheimer?s disease-related dementias (ADRD)

Closes 9/30/2026$2M – $10MGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The National Institute of Neurological Disorders and Stroke (NINDS) is seeking ambitious research projects to investigate mechanisms of neurodegeneration in Alzheimer’s disease-related dementias (ADRD). The program aims to support collaborative research networks, known as "Centers without Walls," which bring together diverse expertise from different institutions to tackle complex neurological problems. The research should focus on elucidating novel ADRD mechanisms, identifying therapeutic targets, biomarkers, and other factors influencing ADRD susceptibility, resilience, and pathology. • The program is anticipated to support teams that combine multiple approaches, such as state-of-the-art technologies, disease-relevant models, clinical science, and human specimens. • One awardee team will serve as a coordinating center for all awardees to facilitate recurring meetings, data harmonization and sharing, cross-site communication, and support the implementation of inter-laboratory rigor and reproducibility plans. • The program is informed by key priorities from the ADRD Summit 2025, including embracing ADRD complexity and breaking down topic- and disease-based silos. • The program is intended to provide a mechanistic foundation for future translational and clinical ADRD research.

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

[email protected]

Key dates

Opened
3/11/2026
Closes
9/30/2026
Projected award
7/1/2027

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
RFA-NS-26-032

Budget estimate

$2,000,000 – $10,000,000

The estimated funding for this opportunity is $10,000,000, and it is anticipated to support 5 awards. The budget amount may vary depending on the specific research projects and the number of awards. The funding is intended to support collaborative research networks, and the budget amount may be influenced by the complexity of the research, the number of institutions involved, and the duration of the project.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 72%

Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)

Closes 11/9/2026Opened 2/12/2026

U.S. National Institutes of Health·United States of America

69% match

BRAIN Initiative: Development and Validation of Novel Tools and New Approaches for Neuroscience Research

Closes 6/9/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

69% match

Functional Target Validation for Alzheimer's Disease-Related Dementias

Closes 11/5/2026Opened 3/11/2026

U.S. National Institutes of Health·United States of America

69% match

BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)

Closes 11/8/2027Opened 5/22/2025

U.S. National Institutes of Health·United States of America

68% match

BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 6/9/2025

U.S. Administration for Community Living·United States of America

68% match

Alzheimer's Disease Programs Initiative (ADPI) - States and Community Grants (Winter 2025)

Closes 6/1/2028Opened 7/31/2024

U.S. National Institutes of Health·United States of America

68% match

NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 Independent Clinical Trial Not Allowed)

Closes 5/26/2027Opened 6/9/2025

U.S. National Institutes of Health·United States of America

68% match

Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)

Closes 5/7/2028Opened 12/30/2024

U.S. Food and Drug Administration·United States of America

68% match

Studies Addressing Rare Neurodegenerative Diseases including ALS

Rolling / TBD closeOpened 8/14/2024

U.S. National Institutes of Health·United States of America

68% match

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Closes 11/5/2027Opened 11/15/2021

U.S. National Institutes of Health·United States of America

67% match

Data Coordinating Center for the Aging and Alzheimer?s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 6/20/2025

U.S. Administration for Community Living·United States of America

67% match

Alheimer's Disease Programs Initiative (ADPI) - State Programs for Dementia Specific Respite

Closes 7/29/2034Opened 10/19/2026

U.S. National Institutes of Health·United States of America

67% match

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

Closes 11/19/2026Opened 8/23/2023

U.S. National Institutes of Health·United States of America

67% match

Establishing a Research Network to Guide Foundational Research on Human Consciousness

Closes 2/7/2027Opened 4/28/2026

U.S. National Institutes of Health·United States of America

67% match

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Closes 6/17/2027Opened 8/13/2026

U.S. National Institutes of Health·United States of America

67% match

BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)

Closes 2/8/2027Opened 6/16/2023

U.S. Department Of Defense·Maryland

66% match

RFI Alzheimer’s Research Program (AZRP) Public

Closes 12/4/2026Opened 10/27/2026

U.S. National Institutes of Health·United States of America

66% match

NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 Independent Clinical Trial Not Allowed)

Closes 5/26/2027Opened 6/9/2025

U.S. National Institutes of Health·United States of America

66% match

BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iBCP (RM1 Clinical Trial Not Allowed)

Closes 6/23/2028Opened 8/28/2025

U.S. Administration for Community Living·United States of America

66% match

Alzheimer's Disease Programs Initiative (ADPI) - States and Community Grants

Closes 7/29/2034Opened 10/19/2026

U.S. Administration for Community Living·United States of America

66% match

Alzheimer's Disease Programs Initiative (ADPI) - Developing Dementia-Capable Community Health Worker Programs in the National Aging Network

Closes 5/2/2027Opened 9/25/2026

U.S. National Institutes of Health·United States of America

66% match

BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System

Closes 1/27/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

66% match

The NIA Genetics of Alzheimer's Disease Data Storage Site (NIAGADS)

Closes 10/31/2026Opened 5/18/2026

U.S. National Institutes of Health·United States of America

65% match

Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure ? Clinical Coordinating Center (CCC) & Data Coordinating Center (DCC)

Closes 10/31/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

65% match

Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure ? Clinical Research Sites (U24 Clinical Trial Not Allowed)

Closes 10/31/2027Opened 9/10/2026